InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-25.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Momtazee James C, 董事. Insider active across 3 companies, notably PRA Health Sciences, Inc.. Aggregated, 29 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €1m. History available since 1 June 2021. The latest transaction was disclosed on 17 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Momtazee James C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报29 总计
405 股0Common SharesSEC:0001140361-26-029193:0
3,990 股Common StockSEC:0001470831-26-000628:0
469 股0Common SharesSEC:0001209181-26-000003:0
94 股@ US$29.830.0000% mcap2.2% 占其流量Common SharesSEC:0001209181-26-000003:1
609 股0Common SharesSEC:0001140361-26-002087:0
789 股0Common SharesSEC:0001140361-25-038996:0
14,524 股0Common SharesSEC:0001140361-25-034930:0
1,201 股0Common SharesSEC:0001140361-25-026648:0
6,589 股0Common StockSEC:0000950170-25-089652:0
1,379 股0Common SharesSEC:0001140361-25-014801:0
1,248 股0Common SharesSEC:0001140361-25-002101:0
1,231 股0Common SharesSEC:0001140361-24-044061:0
3,056 股@ US$12.1232.2% 占其流量Common SharesSEC:0001140361-24-041232:0
16,406 股0Common SharesSEC:0001140361-24-040984:0
1,555 股0Common SharesSEC:0001140361-24-034280:0
1,490 股0Common SharesSEC:0001140361-24-022619:0
1,570 股0Common SharesSEC:0001140361-24-003554:0
1,594 股0Common SharesSEC:0001140361-23-048777:0
6,752 股@ US$11.17100.0% 占其流量Common SharesSEC:0001140361-23-044653:0
17,825 股0Common SharesSEC:0001140361-23-044043:0
1,664 股0Common SharesSEC:0001140361-23-033548:0
1,351 股0Common SharesSEC:0001140361-23-016868:0
2,447 股0Common SharesSEC:0001140361-23-000728:0
3,404 股0Common SharesSEC:0001140361-22-039660:0
50,000 股0Common SharesSEC:0001140361-22-033878:0
29 条申报中的 25 条
About Momtazee James C
MOMTAZEE JAMES C is Administrateur at Roivant Sciences Ltd., BridgeBio Pharma, Inc. and PRA Health Sciences, Inc. He has 28 filings, and in the recent sample of 28 filings, the activity consists of attributions, with EUR 1025208 of buys and EUR 0 of sells between 2021-06-03 and 2026-06-24. The largest listed filing concerns BridgeBio Pharma, Inc. on 2022-01-03 for EUR 1025207.996651328.
